Nazca has acquired a majority stake in Nutris, a leading innovator in functional gummies, signaling a significant investment aimed at fueling the company's ambitious growth and international expansion.
Information on the Target
Nutris is an innovative nutraceutical company specializing in the production of functional gummies, a rapidly growing niche due to its appealing and novel form. The company focuses on creating scientifically validated functional projects aimed at improving health outcomes. With a strong presence in the market, Nutris sells its products through pharmacies, health food stores, and specialty shops.
Founded in 2013 and located in Madrid, Nutris has positioned itself as a leader in the manufacture of functional gummies in Europe, achieving substantial annual growth of 60%. The company has seen its revenue increase from €16 million in 2020 to an estimated €25 million in 2021, with an EBITDA margin around 20%. The founders, Pedro de La Fuente and Inés de Santos, will remain at the helm, ensuring continuity in the company's strategic vision.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The Spanish nutraceutical industry has experienced significant growth, driven by consumer preferences shifting towards natural and functional food products. The growing awareness of health and wellness among consumer
Similar Deals
InvestIndustrial → Grupo Alacant
2024
ACON Investments, DeA Capital Alternative Funds → Romar Global Care Group
2024
Nazca
invested in
Nutris
in 2021
in a Growth Equity & Expansion Capital deal
Disclosed details
Revenue: $29M
EBITDA: $6M